Aigen Investment Management, LP Allogene Therapeutics, Inc. Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$23.49 - $35.8 $272,859 - $415,852	-11,616 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$25.79 - $39.02 $423,936 - $641,410	-16,438 Reduced 58.59%	11,616 $410,000
Q4 2020 Feb 12, 2021	BUY	$25.24 - $43.45 $708,082 - $1.22 Million	28,054 New	28,054 $708,000
Q2 2020 Aug 10, 2020	SELL	$18.39 - $54.04 $413,756 - $1.22 Million	-22,499 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$18.22 - $28.25 $148,092 - $229,616	8,128 Added 56.56%	22,499 $437,000
Q4 2019 Feb 04, 2020	BUY	$24.82 - $31.4 $356,688 - $451,249	14,371 New	14,371 $373,000

163

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $233M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.